Literature DB >> 8694619

Acute-phase responses to cardiopulmonary bypass in children weighing less than 10 kilograms.

J Butler1, V L Pathi, R D Paton, R W Logan, K J MacArthur, M P Jamieson, J C Pollock.   

Abstract

BACKGROUND: Cardiopulmonary bypass induces a systemic inflammatory response. This study investigated, in a pediatric population, cytokine-induced responses and their potential modification by intraoperative steroid administration.
METHODS: Markers of the acute-phase response were measured perioperatively in 24 children weighing less than 10 kg undergoing cardiac operations. Those having operations with cardiopulmonary bypass were randomized to receive either no steroid (group I, n = 8) or 10 mg/kg methylprednisolone in the pump prime (group II, n = 10); patients undergoing nonbypass procedures were controls (group III, n = 6).
RESULTS: In all groups, plasma interleukin-6 level was elevated (p < 0.01) above baseline throughout the post-operative period, peaking earlier in group I. Levels of C-reactive protein peaked at 48 hours, and postoperative core temperature was raised in all groups. Levels of interleukin-6 from 2 to 6 hours and C-reactive protein at 24 hours postoperatively were greater (p < 0.05) in group I than in group II. Maximum interleukin-6 level, C-reactive protein level, and temperature were all significantly greater in group I than in group III. Maximum interleukin-6 level correlated with maximum C-reactive protein level in group I only (rs = 0.76; p < 0.05) and showed no association with temperature. Duration of bypass did not correlate with levels of interleukin-6.
CONCLUSIONS: This study demonstrated a marked acute-phase response to operation; the greater response to procedures with cardiopulmonary bypass was abrogated by intraoperative steroid administration. The importance of interleukin-6 as an inducer of acute phase proteins after bypass is supported by its association with C-reactive protein levels, but other factors must be important in the induction of pyrexia.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8694619

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  13 in total

1.  Risks and benefits of preoperative high dose methylprednisolone in surgical patients: a systematic review.

Authors:  S Sauerland; M Nagelschmidt; P Mallmann; E A Neugebauer
Journal:  Drug Saf       Date:  2000-11       Impact factor: 5.606

2.  Superior biocompatibility of heparin-bonded circuits in pediatric cardiopulmonary bypass.

Authors:  T Ozawa; K Yoshihara; N Koyama; S Yamazaki; Y Takanashi
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  1999-12

3.  Extracorporeal membrane oxygenation causes loss of intestinal epithelial barrier in the newborn piglet.

Authors:  Ashish R Kurundkar; Cheryl R Killingsworth; R Britt McIlwain; Joseph G Timpa; Yolanda E Hartman; Dongning He; Rajendra K Karnatak; Mary L Neel; John P Clancy; G M Anantharamaiah; Akhil Maheshwari
Journal:  Pediatr Res       Date:  2010-08       Impact factor: 3.756

4.  Cytokine response in children undergoing surgery for congenital heart disease.

Authors:  Ashish B Madhok; Kaie Ojamaa; Viraga Haridas; Vincent A Parnell; Savita Pahwa; D Chowdhury
Journal:  Pediatr Cardiol       Date:  2006-07-06       Impact factor: 1.655

Review 5.  Pharmacokinetics and Dosing of Anti-infective Drugs in Patients on Extracorporeal Membrane Oxygenation: A Review of the Current Literature.

Authors:  Jennifer Sherwin; Travis Heath; Kevin Watt
Journal:  Clin Ther       Date:  2016-08-21       Impact factor: 3.393

6.  Effect of dexamethasone on postoperative cardiac troponin T production in pediatric cardiac surgery.

Authors:  Ignacio Malagon; Karin Hogenbirk; Johanes van Pelt; Mark G Hazekamp; James G Bovill
Journal:  Intensive Care Med       Date:  2005-09-16       Impact factor: 17.440

7.  Macrophage migration inhibitory factor in pediatric patients undergoing surgery for congenital heart repair.

Authors:  Sanah Merchant; Sumekala Nadaraj; Devyani Chowdhury; Vincent A Parnell; Cristina Sison; Edmund J Miller; Kaie Ojamaa
Journal:  Mol Med       Date:  2008 Mar-Apr       Impact factor: 6.354

Review 8.  Clinical pharmacology considerations for children supported with ventricular assist devices.

Authors:  Jennifer Sherwin; Elizabeth Thompson; Kevin D Hill; Kevin Watt; Andrew J Lodge; Daniel Gonzalez; Christoph P Hornik
Journal:  Cardiol Young       Date:  2018-07-11       Impact factor: 1.093

9.  Plasma concentrations of inflammatory cytokines rise rapidly during ECMO-related SIRS due to the release of preformed stores in the intestine.

Authors:  R Britt McILwain; Joseph G Timpa; Ashish R Kurundkar; David W Holt; David R Kelly; Yolanda E Hartman; Mary Lauren Neel; Rajendra K Karnatak; Robert L Schelonka; G M Anantharamaiah; Cheryl R Killingsworth; Akhil Maheshwari
Journal:  Lab Invest       Date:  2009-11-09       Impact factor: 5.662

10.  Physiologically Based Pharmacokinetic Approach to Determine Dosing on Extracorporeal Life Support: Fluconazole in Children on ECMO.

Authors:  Kevin M Watt; Michael Cohen-Wolkowiez; Jeffrey S Barrett; Michael Sevestre; Ping Zhao; Kim L R Brouwer; Andrea N Edginton
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2018-08-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.